PRA Health Sciences, Inc. (PRAH) Updates FY17 Earnings Guidance

PRA Health Sciences, Inc. (NASDAQ:PRAH) issued an update on its FY17 earnings guidance on Monday morning. The company provided earnings per share guidance of $3.11-$3.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.15. The company issued revenue guidance of $1.825-$1.855 billion, compared to the consensus revenue estimate of $1.82 billion.

Shares of PRA Health Sciences, Inc. (NASDAQ PRAH) traded up 0.20% during mid-day trading on Monday, reaching $74.23. 694,032 shares of the company’s stock traded hands. PRA Health Sciences, Inc. has a one year low of $46.52 and a one year high of $79.98. The firm has a market cap of $4.64 billion, a price-to-earnings ratio of 44.34 and a beta of 0.45. The firm’s 50-day moving average is $75.01 and its 200 day moving average is $66.37.

A number of brokerages have recently issued reports on PRAH. Jefferies Group LLC set a $73.00 target price on shares of PRA Health Sciences and gave the stock a buy rating in a research report on Thursday, June 1st. Bank of America Corporation began coverage on shares of PRA Health Sciences in a research report on Monday, June 26th. They set a buy rating and a $89.00 target price on the stock. Credit Suisse Group restated an outperform rating and set a $76.00 target price (up from $69.00) on shares of PRA Health Sciences in a research report on Tuesday, June 6th. Citigroup Inc. restated a buy rating and set a $90.00 target price (up from $73.00) on shares of PRA Health Sciences in a research report on Wednesday, June 28th. Finally, BidaskClub lowered shares of PRA Health Sciences from a strong-buy rating to a buy rating in a research report on Monday, July 31st. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The stock presently has a consensus rating of Buy and an average target price of $73.00.

ILLEGAL ACTIVITY WARNING: “[[title]]” was first published by [[site]] and is the property of of [[site]]. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at [[permalink]].

PRA Health Sciences Company Profile

PRA Health Sciences, Inc is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases.